LC526 Lipo-C (FAT BLASTER)
Lipo-C FAT BLASTER · LC526
High-strength lipotropic injection (526 mg/mL total: L-carnitine, MIC, B12, B6, NADH) sold for fat-loss clinic protocols.
Key takeaways
- Seven-ingredient lipotropic blend at 526 mg/mL total — L-carnitine (300 mg/mL) is over half the blend by mass.
- Clinic protocols typically use 1 mL IM or subQ one to three times per week.
- No controlled trials of this blend exist; evidence for MIC-style lipotropic shots producing meaningful weight loss is weak overall.
- The NADH component is chemically unstable and poorly characterized in compounded injectables.
Overview
What it is
LC526 Lipo-C FAT BLASTER is a high-strength compounded lipotropic injection sold in weight-loss clinics, with 526 mg of total active ingredients per mL, which is where the name comes from. L-carnitine dominates the blend at 300 mg/mL (about 57% by mass); the full formula is in the composition table below.
How it's used
Clinic protocols typically inject 1 mL intramuscularly or subcutaneously one to three times per week, titrated by 0.5 mL depending on response and tolerance.
What the evidence says
There are no controlled trials of this blend, and no evidence it outperforms a basic MIC shot. The rationale is plausible biochemistry (carnitine shuttles fatty acids into mitochondria, the MIC triad supports hepatic fat export), but human weight-loss data for lipotropic injections is thin. The NADH component is also chemically unstable in compounded injectables. We list it for catalog completeness, not as an evidence-based therapy. It's excluded from the plotter because a seven-ingredient blend has no single PK curve.
Composition
| Ingredient | Amount | Role |
|---|---|---|
| L-carnitine | 300 mg/mL | Fatty-acid transport into mitochondria |
| Methionine | 25 mg/mL | MIC core — hepatic fat metabolism, methyl donor |
| Inositol | 50 mg/mL | MIC core — hepatic fat export |
| Choline chloride | 50 mg/mL | MIC core — hepatic fat export |
| Cyanocobalamin (B12) | 1 mg/mL | Metabolic cofactor |
| Pyridoxine (B6) | 50 mg/mL | Metabolic cofactor |
| NADH | 50 mg/mL | Redox cofactor (unstable in injectables) |
Reported dosing protocols
Protocols reported in research literature and clinic/community use — informational context, not a dosing recommendation.
| Use case | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Weight-loss clinic protocol | 1 mL (526 mg total) | IM or SubQ | 1–3× weekly | Ongoing, titrated by 0.5 mL |
Frequently asked questions
What does the "526" in LC526 mean?
It is the total active mass per mL: 300 + 25 + 50 + 50 + 1 + 50 + 50 = 526 mg/mL across the seven ingredients. The same naming pattern shows up in sibling blends (LC120, LC216, LC425).
Is LC526 Lipo-C proven to cause weight loss?
No. There are no controlled trials of this specific blend, and the broader evidence that MIC-style lipotropic injections produce meaningful weight loss in humans is thin — mostly small older studies and clinic testimonials. It is a compounded clinic product, not an evidence-based therapy.
Why can't I plot LC526 in the plotter?
It is a seven-ingredient blend, not a single compound, so it has no single half-life or PK curve to model. None of the ingredients have pharmacokinetic characterization as a combined injection.
References
- Vendor blend (informational) — 526 mg/mL total: carnitine 300 / methionine 25 / inositol 50 / choline 50 / B12 1 / B6 50 / NADH 50; not plotted.
Related compounds
LC120 Lipo-C
Lipotropic injection of methionine, choline, carnitine, and dexpanthenol used in weight-loss protocols.
LC216 Lipo-B
Lipotropic B-complex/MIC injection (carnitine, arginine, methionine, inositol, choline, B6/B5/B12).
LC425 Lipo-C (FOCUS)
Energy-focused Lipo-C variant (ATP, Eria jarensis, carnitine, MIC, lidocaine) for weight-loss/energy protocols.
Comments
Loading comments…